Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 06, 2023 19:14 ET | Source: Lotus Pharmaceutical

NRx Pharmaceuticals, Lotus Pharmaceuticals y Alvogen Inc. anuncian colaboración para desarrollar y comercializar NRX-101

NRx Pharmaceuticals, Lotus Pharmaceuticals y Alvogen colaborarán en el desarrollo y la comercialización de NRX-101 para la depresión bipolar resistente al tratamiento suicida (S-TRBD) para los...
June 05, 2023 07:00 ET | Source: Lotus Pharmaceutical

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for...